Greenstein Leonard M.
Insider CIK 1519692 · ELGX VP Finance & Corp Controller · CARL CFO, Treasurer · TARS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CARL CARLSMED, INC. | A Award | 2026-01-28 | 2026-01-30 | 44,977 | — | $0 | 188,346 | SEC↗ |
| CARL CARLSMED, INC. | A Award deriv | 2025-07-22 | 2025-07-24 | 71,429 | — | $0 | 155,102 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-04-20 | 2023-04-21 | 5,000 | $14.02 | $70.1K | 26,785 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-23 | 2023-03-23 | 346 | $12.15 | $4.2K | 31,785 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-22 | 2023-03-23 | 332 | $12.64 | $4.2K | 32,131 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-21 | 2023-03-23 | 326 | $12.89 | $4.2K | 32,463 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-20 | 2023-03-21 | 333 | $12.61 | $4.2K | 32,789 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-17 | 2023-03-21 | 316 | $13.28 | $4.2K | 33,122 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-17 | 5,000 | $13.44 | $67.2K | 33,438 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-17 | 313 | $13.43 | $4.2K | 38,438 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2023-03-15 | 2023-03-17 | 4,462 | — | $0 | 13,388 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2023-03-15 | 2023-03-17 | 4,462 | — | $0 | 38,751 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-03-08 | 2023-03-10 | 27,160 | — | $0 | 27,160 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-03-08 | 2023-03-10 | 40,097 | — | $0 | 40,097 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-02-16 | 2023-02-17 | 5,000 | $15.12 | $75.6K | 34,289 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-01-19 | 2023-01-20 | 5,000 | $14.56 | $72.8K | 39,289 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-12-15 | 2022-12-16 | 5,000 | $14.64 | $73.2K | 44,289 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-11-17 | 2022-11-18 | 5,000 | $16.54 | $82.7K | 49,289 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-10-20 | 2022-10-28 | 4,877 | $15.90 | $77.5K | 54,412 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-10-20 | 2022-10-28 | 123 | $16.62 | $2.0K | 54,289 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-09-15 | 2022-09-16 | 5,000 | $16.03 | $80.2K | 59,289 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-08-18 | 2022-08-19 | 5,000 | $16.30 | $81.5K | 64,289 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-03-09 | 2022-03-11 | 60,846 | — | $0 | 60,846 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-03-09 | 2022-03-11 | 17,850 | — | $0 | 17,850 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2021-01-07 | 2021-01-08 | 40,999 | — | $0 | 40,999 | SEC↗ |
| ELGX ENDOLOGIX INC /DE/ | D To issuer deriv | 2013-10-03 | 2013-10-04 | 4,750 | — | $0 | 7,250 | SEC↗ |
| ELGX ENDOLOGIX INC /DE/ | D To issuer deriv | 2013-10-03 | 2013-10-04 | 13,062 | — | $0 | 19,938 | SEC↗ |
| ELGX ENDOLOGIX INC /DE/ | D To issuer | 2013-10-03 | 2013-10-04 | 14,472 | — | $0 | 1,330 | SEC↗ |
| ELGX ENDOLOGIX INC /DE/ | D To issuer | 2013-09-05 | 2013-09-05 | 1,973 | $16.17 | $31.9K | 15,802 | SEC↗ |
| ELGX ENDOLOGIX INC /DE/ | S Sale | 2013-05-28 | 2013-05-28 | 1,253 | $14.01 | $17.6K | 16,445 | SEC↗ |
| ELGX ENDOLOGIX INC /DE/ | A Award | 2012-09-09 | 2012-10-02 | 14,472 | $12.62 | $182.6K | 17,108 | SEC↗ |
| ELGX ENDOLOGIX INC /DE/ | A Award | 2012-09-09 | 2012-09-11 | 14,472 | $13.82 | $200.0K | 17,108 | SEC↗ |
| ELGX ENDOLOGIX INC /DE/ | A Award | 2012-09-09 | 2012-09-11 | 14,472 | $12.62 | $182.6K | 17,108 | SEC↗ |